Arcturus Therapeutics Holdings (ARCT) Gains from Investment Securities (2018 - 2026)

Arcturus Therapeutics Holdings has reported Gains from Investment Securities for 9 years, with the latest figure at $34000.0 in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities changed N/A year-over-year to $34000.0; the trailing twelve-month figure through Mar 2026 stood at $34000.0 (changed N/A YoY), and the FY2025 full-year result was $2.0 million, down 74.88% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at $34000.0, down from $2.0 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $3.8 million in Q2 2022, with the low at -$35.3 million in Q3 2022.
• Historically, Gains from Investment Securities has averaged -$3.1 million across 5 years, with a median of $1.0 million in 2025.
• Annual changes were most pronounced in 2022 — Gains from Investment Securities slumped 1134.15% — and 2024, when it soared 645.02%.
• Arcturus Therapeutics Holdings' Gains from Investment Securities stood at $2.9 million in 2022, then tumbled by 117.24% to -$502000.0 in 2023, then soared by 645.02% to $2.7 million in 2024, then decreased by 25.83% to $2.0 million in 2025, then plunged by 98.32% to $34000.0 in 2026.
• The last three Gains from Investment Securities figures came in at $34000.0 (Q1 2026), $2.0 million (Q4 2025), and $2.7 million (Q1 2024), per Business Quant data.